Diloxanide furoate|CAS 3736-81-0|DC Chemicals

Cas No.:	3736-81-0
Chemical Name:	Diloxanide furoate
Synonyms:	4-(2,2-Dichloro-N-methylacetamido)phenyl furan-2-carboxylate;2,2-Dichloro-N-(4-hydroxyphenyl)-N-methylacetamide 2-furoic acid ester;[4-[(2,2-dichloroacetyl)-methylamino]phenyl] furan-2-carboxylate;Diloxanide furoate;Furamide;Amebiazol;Diclofurazol;Diloxanid furoate;Entamide 2-furoate;Entamide furoate;Furamide (amebicide);Furentomin;Histomibal;Miforon;NCGC00016637-03;MFCD00083302;EN300-18538237;AB00383052_13;Diloxanide furoate (USP);DTXSID8048999;NCGC00016637-07;HMS2093N21;Diloxanide furoate (TN);SR-01000003134-4;cid_19529;3736-81-0;SMR000058857;Prestwick2_000903;D02480;SPBio_002945;DILOXANIDE FUROATE;BSPBio_000746;Tox21_113492;BDBM70295;SR-01000003134;FT-0752403;DILOXANIDE FUROATE [USP MONOGRAPH];Q-200989;AKOS016014036;Diloxanidi furoas;NCGC00023178-05;furan-2-carboxylic acid [4-[(2,2-dichloroacetyl)-methyl-amino]phenyl] ester;DILOXANIDE FUROATE [MART.];Q799564;Diloxanide furoate [USP];Pharmakon1600-01505532;HMS2234P06;CCG-213477;4-((Dichloroacetyl)methylamino)phenyl 2-furoate;YP4N72IW34;C07637;NSC-759146;MLS000028653;[4-[2,2-bis(chloranyl)ethanoyl-methyl-amino]phenyl] furan-2-carboxylate;AB00383052;NSC759146;NCGC00016637-01;NCGC00016637-06;CHEMBL1334860;Diloxanide furoate, United States Pharmacopeia (USP) Reference Standard;SR-01000003134-2;DILOXANIDE FUROATE [WHO-DD];NCGC00016637-10;CB 8073;4-(2,2-Dichlor-N-methylacetamido)phenyl 2-furancarboxylat;4-(2,2-Dichlor-N-methylacetamido)phenyl 2-furancarboxylat [IUPAC];4-(N-Methyl-2,2-dichloroacetamideo)phenyl 2-furoate;UNII-YP4N72IW34;NCGC00016637-02;Tox21_113492_1;DILOXANIDE FUROATE [WHO-IP];NSC 759146;CHEBI:4601;8073 CB;2,2-DICHLORO-N-[4-HYDROXYPHENYL]-N-METHYLACETAMIDE 2-FUROIC ACID ESTER;NS00030183;DB14638;Prestwick3_000903;BPBio1_000822;DILOXANIDE FUROATE [MI];4-(2,2-Dichlor-N-methylacetamido)phenyl 2-furoat;NCGC00023178-04;NCGC00016637-04;MS-24905;MLS001148648;2,2-Dichloroacetamideo-4-N-methylphenyl 2-furoate;SCHEMBL23381;NCGC00016637-05;Diloxanide furoate 100 microg/mL in Acetonitrile;CS-4751;HMS1570F08;F85244;HMS2097F08;Opera_ID_1633;2-Furoic acid, ester with 2,2-dichloro-4'-hydroxy-N-methylacetanilide;DTXCID8028925;4-(n-methyl-2,2-dichloroacetamido)phenyl 2-furoate;2-Furancarboxylic acid, 4-[(2,2-dichloroacetyl)methylamino]phenyl ester;EINECS 223-108-1;2-furancarboxylic acid [4-[(2,2-dichloro-1-oxoethyl)-methylamino]phenyl] ester;[4-[(2,2-dichloroacetyl)-methyl-amino]phenyl] furan-2-carboxylate;BRD-K10974103-001-14-6;HY-B1147;2-Furancarboxylic acid, 4-((dichloroacetyl)methylamino)phenyl ester;SBI-0206798.P001;CAS-3736-81-0;Prestwick0_000903;4-(2,2-Dichlor-N-methylacetamido)phenyl 2-furoat [IUPAC];Dichlofurazol;BRD-K10974103-001-03-9;DILOXANIDI FUROAS [WHO-IP LATIN];HMS3714F08;Prestwick1_000903;2,2-dichloroacetamido-4-n-methylphenyl 2-furoate;NCGC00023178-03;HMS3371I07;DILOXANIDE FUROATE [USP-RS]
SMILES:	O=C(C1=CC=CO1)OC2=CC=C(N(C(C(Cl)Cl)=O)C)C=C2
Formula:	C₁₄H₁₁NO₄Cl₂
M.Wt:	328.14744
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.